Kromek Group PLC Collaboration agreement with new CT partner (5662S)
November 07 2023 - 2:00AM
UK Regulatory
TIDMKMK
RNS Number : 5662S
Kromek Group PLC
07 November 2023
7 November 2023
Kromek Group plc
("Kromek" or the "Company" or the "Group")
Collaboration agreement with new CT technology partner
Kromek and global technology solutions provider to develop
next-generation CT detector technology
Kromek Group plc (AIM: KMK), a leading developer of radiation
and bio-detection technology solutions for the advanced imaging and
CBRN detection segments, announces that it has entered into a
collaboration agreement with a new partner to develop Cadmium Zinc
Telluride ("CZT") based detectors for photon counting computed
tomography applications in the medical imaging sector.
The new blue-chip partner is a technology solutions provider to
over 100,000 customers globally for a range of applications,
including healthcare.
As part of the collaboration, Kromek will integrate its CZT
sensors with the partner's read-out electronics to ensure optimal
computed tomography ("CT") detection system performance. As the
project progresses towards commercialisation, the Group will ensure
production capability is available to support commercial demand
ramp-up.
Arnab Basu, CEO of Kromek, said: "At Kromek, we have a strong
track record of teaming up with leading global technology partners
to advance new imaging solutions. Our CZT-based products are the
enabling technology in ultra high-resolution systems. These systems
provide clinicians with greater image quality that leads to earlier
diagnosis, better patient outcomes and ultimately saves lives. We
look forward to working with this new blue-chip partner to make
another important advancement in medical imaging technology."
For further information, please contact:
Kromek Group plc
Arnab Basu, CEO
Paul Farquhar, CFO +44 (0)1740 626 060
Cavendish Capital Markets Limited (Nominated
Adviser and Broker)
Geoff Nash/Giles Balleny/Seamus Fricker -
Corporate Finance
Tim Redfern/Charlotte Sutcliffe - ECM
Michael Johnson/Tamar Cranford-Smith - Sales +44 (0)20 7220 0500
Gracechurch Group (Financial PR)
Harry Chathli/Claire Norbury/Henry Gamble +44 (0)20 4582 3500
Kromek Group plc
Kromek Group plc is a leading developer of radiation detection
and bio-detection technology solutions for the advanced imaging and
CBRN detection segments. Headquartered in County Durham, UK, Kromek
has manufacturing operations in the UK and US, delivering on the
vision of enhancing the quality of life through innovative
detection technology solutions.
The advanced imaging segment comprises the medical (including CT
and SPECT), security and industrial markets. Kromek provides its
OEM customers with detector components, based on its core cadmium
zinc telluride (CZT) platform, to enable better detection of
diseases such as cancer and Alzheimer's, contamination in
industrial manufacture and explosives in aviation settings.
In CBRN detection, the Group provides nuclear radiation
detection solutions to the global homeland defence and security
market. Kromek's compact, handheld, high-performance radiation
detectors, based on advanced scintillation and solid-state readout
technology, are primarily used to protect critical infrastructure,
events, personnel and urban environments from the threat of 'dirty
bombs'.
The Group is also developing bio-security solutions in the CBRN
detection segment. These consist of fully automated and autonomous
systems to detect a wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange,
under the trading symbol 'KMK'.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGRBFBJTMTIMTPJ
(END) Dow Jones Newswires
November 07, 2023 02:00 ET (07:00 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kromek (LSE:KMK)
Historical Stock Chart
From Jul 2023 to Jul 2024